QLTI – QLT Inc, is a Biotechnology company, engaged in development and commercialization of ocular products.
QLTI – QLT, Inc
|Fundamentals||Previously closed at||1.43|
|Analysts opinion||After a restructuring bout of several years, and cancelled merger attempts with Auxiliam Pharma and InSite Vision, QLT’s price had dropped 64%. Now, QLT and Aegerion have announced a strategic merger, resulting in a combined company named “Novelion Therepeutics”. Under the merger terms, 1 share of Aegerion will be given in return for 1.0256 shares of QLT. An investor syndicate will be purchasing $22 Million worth QLT stocks at $1.76 per stock. Analyst confidence meter, a proprietary algorithm of Stockal gives75% buy based on analyst ratings.|
|Sentiments||The sentiment index is 200% positive according to Stockal proprietary algorithm.|
|Social Media Pulse||The stock has 50% lower social media chatter than usual.|